Last updated on September 2019

Gabapentin for Bipolar & Cannabis Use Disorders

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Bipolar II Disorder | Cannabis Use Disorder | Drug abuse | Bipolar I Disorder
  • Age: Between 18 - 65 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Meets DSM-V criteria for Bipolar Disorder
  • Meets DSM-V criteria for Cannabis Use Disorder
  • Using at least one mood stabilizing medication

Exclusion Criteria:

  • Serious medical or non-inclusionary psychiatric disease
  • Concomitant use of benzodiazepine medications or any medications hazardous if taken with gabapentin
  • History of clinically significant brain injury
  • Presence of non-MRI safe material, or clinically significant claustrophobia.

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.